PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Expanding APAC presence, Insilico Medicine seals strategic collaboration on AI-driven mash therapy development with Korean Biotech Therasid Bioscience

Expanding APAC presence, Insilico Medicine seals strategic collaboration on AI-driven mash therapy development with Korean Biotech Therasid Bioscience
2024-07-24
(Press-News.org) Insilico Medicine(“Insilico”), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, recently announces that the company has entered a strategic collaboration with Therasid Bioscience, an innovative biotechnology company founded in South Korea, to utilize advanced AI technology to co-develop novel therapies for the treatment of metabolic dysfunction associated steatohepatitis (MASH).  

 MASH, previously known as Non-alcoholic steatohepatitis (NASH), is a severe form of non-alcoholic fatty liver disease (NAFLD), characterized by liver inflammation and damage caused by a buildup of fat. Potentially progressing to liver cirrhosis and hepatic cellular carcinoma, MASH affects approximately 5% adults globally, according to latest epidemiology results. However, the complexity and silent progression of the disease pose challenges for diagnosis and treatment. 

By leveraging Insilico’s validated generative AI platform, Pharma.AI, and dedicated drug discovery and development team, along with Therasid’s robust R&D proficiency and deep insights into MASH, both companies aim to combine their unique strengths to deliver novel therapies at an accelerated pace, through the strategic collaboration. 

“We are thrilled to embark on this significant collaboration with Insilico Medicine. The integration of Insilico’s advanced AI capabilities with our extensive research experience in MASH holds immense potential,” says Jay H.J. Kim, CEO of Therasid Bioscience. “With joint efforts, we hope to accelerate the discovery and development of novel, more efficacious treatments, ultimately improving the lives of millions of patients worldwide.” 

“This partnership marks another significant step in expanding our presence in the APAC market, enabling us to forge strong local collaborations and enhance our global reach,” says Feng Ren, PhD, Co-CEO and chief scientific officer of Insilico Medicine. “With the support of Pharma.AI, our ever-growing AI drug discovery platform, we hope to shift MASH treatment with unprecedented efficiency.” 

Founded in 2014, Insilico Medicine is a pioneer in using generative AI for drug discovery and development. Insilico first described the concept of using generative AI for the design of novel molecules in a peer-reviewed journal in 2016, which laid the foundation for the commercially available Pharma.AI platform spanning across biology, chemistry and clinical development. Powered by Pharma.AI, Insilico has nominated 18 preclinical candidates in its comprehensive portfolio of over 30 assets since 2021 and has received IND approval for 7 molecules. Recently, the company published a paper in Nature Biotechnology presenting the entire R&D journey of its lead drug pipeline, INS018_055, from AI algorithms to Phase II clinical trials. 

 

About Insilico Medicine 

Insilico Medicine, a global clinical stage biotechnology company powered by generative AI, is connecting biology, chemistry and clinical trials analysis using next-generation AI systems. The company has developed AI platforms that utilize deep generative models, reinforcement learning, transformers and other modern machine learning techniques for novel target discovery and the generation of novel molecular structures with desired properties. Insilico Medicine is developing breakthrough solutions to discover and develop innovative drugs for cancer, fibrosis, immunity, central nervous system diseases, infectious diseases, autoimmune diseases, and aging-related diseases.  

www.insilico.com 

 

About Therasid Bioscience 

Therasid Bioscience was established in 2017 with a specialty in developing innovative first-in-class drugs for treatment of nonalcoholic steatohepatitis (NASH) or metabolic dysfunction-associated steatohepatitis (MASH), a leading cause of liver cirrhosis-driven mortality. NASH shows a wide spectrum of clinical manifestations primarily based on the severity of inflammation and fibrosis in the diseased liver. The lead pipeline of the company, TB-840, is in front of pre-IND meeting for phase 2a clinical trial in US and Korea. The key strategy of the company to tackle this complex metabolic disease and to develop NASH therapeutics that can benefit patients with diverse NASH profiles starts from a comprehensive understanding of the molecular mechanisms underlying NASH pathogenesis processes including steatosis, inflammation, and fibrosis in multiple cell types implicated in NASH development.  

 

Reference 

[1] Ledford, H. (2024). First US drug approved for a liver disease surging around the world. Nature. https://doi.org/10.1038/d41586-024-00747-9 

[2] Ren, F., et al. A small-molecule TNIK inhibitor targets fibrosis in preclinical and clinical models. Nat Biotechnol (2024). https://doi.org/10.1038/s41587-024-02143-0 

END

[Attachments] See images for this press release:
Expanding APAC presence, Insilico Medicine seals strategic collaboration on AI-driven mash therapy development with Korean Biotech Therasid Bioscience

ELSE PRESS RELEASES FROM THIS DATE:

When it comes to butterflies, people prefer pretty ones. That’s a problem for scientists.

2024-07-24
Research shows humans often perceive attractive people as more intelligent, healthier, better leaders and more trustworthy. It turns out this bias extends to the insect world. A new study by scientists at the USC Dornsife College of Letters, Arts and Sciences reveals that data reported on a popular community science platform is biased. On iNaturalist, butterflies with captivating markings, easily identifiable features or those that are familiar species are reported more frequently than obscure species with no distinct qualities. Why it matters: Online ...

UBC Okanagan study raises concerns about partner violence in queer relationships

2024-07-24
When people think of a concussion or a traumatic brain injury caused by intimate partner violence (IPV), they might picture people in a heterosexual relationship, or a man hurting a woman. But a UBC Okanagan researcher points out that IPV, and its repercussions, is an issue in all relationships. Doctoral student Tori Stranges recently published a paper examining the prevalence and damage done by violence in Two-Spirit, Lesbian, Gay, Bisexual, Trans, Queer (or Questioning), Intersex and Asexual (2SLGBTQIA+) relationships. “It’s very common for people to think that violence doesn’t ...

Human-infecting parasite produces sterile soldiers like ants and termites

Human-infecting parasite produces sterile soldiers like ants and termites
2024-07-24
New research from scientists at UC San Diego’s Scripps Institution of Oceanography finds a tiny freshwater parasite known to cause health problems in humans defends its colonies with a class of soldiers that cannot reproduce. The discovery, published today in the Proceedings of the National Academy of Sciences and funded by the National Institutes of Health, vaults this species of parasitic flatworm into the ranks of complex animal societies such as ants, bees and termites, which also have distinct classes of workers and soldiers that have given up reproduction to serve their colony. When it gets into humans, usually via the consumption of raw or undercooked fish, this species ...

The unintended consequences of success against malaria

The unintended consequences of success against malaria
2024-07-24
For decades, insecticide-treated bed nets and indoor insecticide spraying regimens have been important – and widely successful – treatments against mosquitoes that transmit malaria, a dangerous global disease. Yet these treatments also – for a time – suppressed undesirable household insects like bed bugs, cockroaches and flies. Now, a new North Carolina State University study reviewing the academic literature on indoor pest control shows that as the household insects developed resistance ...

Taco-shaped arthropod from Royal Ontario Museum’s Burgess Shale fossils gives new insights into the history of the first mandibulates

Taco-shaped arthropod from Royal Ontario Museum’s Burgess Shale fossils gives new insights into the history of the first mandibulates
2024-07-24
A new study, led by palaeontologists at the Royal Ontario Museum (ROM) is helping resolve the evolution and ecology of Odaraia, a taco-shaped marine animal that lived during the Cambrian period. Fossils collected by ROM reveal Odaraia had mandibles. Palaeontologists are finally able to place it as belonging to the mandibulates, ending its long enigmatic classification among the arthropods since it was first discovered in the Burgess Shale over 100 years ago and revealing more about early evolution and diversification. The study The Cambrian Odaraia alata and the colonization of nektonic suspension-feeding niches by early mandibulates was published ...

Butterflies accumulate enough static electricity to attract pollen without contact, new research finds

Butterflies accumulate enough static electricity to attract pollen without contact, new research finds
2024-07-24
Butterflies and moths collect so much static electricity whilst in flight, that pollen grains from flowers can be pulled by static electricity across air gaps of several millimetres or centimetres. The finding, published today in the Journal of the Royal Society Interface, suggests that this likely increases their efficiency and effectiveness as pollinators. The University of Bristol team also observed that the amount of static electricity carried by butterflies and moths varies between different species, and that these variations correlate with differences in their ecology, such as whether they visit flowers, are ...

Eyes for Love: Searching for light and a mate in the deep, dark sea, male dragonfishes grow larger eyes than the females they seek

Eyes for Love: Searching for light and a mate in the deep, dark sea, male dragonfishes grow larger eyes than the females they seek
2024-07-24
Chestnut Hill, Mass (07/24/2024) – A small but ferocious predator, the male dragonfish will apparently do anything for love. Or at least to find a mate. A new study by researchers at Boston College found the eyes of the male dragonfish grow larger for mate-seeking purposes, making the dragonfish an anomaly in vertebrate evolution, the team reported today in the Royal Society journal Biology Letters. Like many creatures that inhabit the dark depths of the sea, dragonfishes survive thanks to numerous ...

PNNL scientists tap nation’s fastest computers to explore critical science questions

2024-07-24
RICHLAND, Wash.—Researchers at the Department of Energy’s Pacific Northwest National Laboratory have been awarded more than 3 million node hours on the nation’s most powerful computers to explore questions around pathogens, climate and energy-efficient microelectronics.   Access to the nation’s supercomputers, granted to Margaret Cheung, Daniel Mejia Rodriguez and Po-Lun Ma, is a coveted prize among scientists. The node hours represent an investment of several million dollars in computing time awarded to PNNL scientists to explore important science questions.   The awards are among 44 projects awarded through ...

Peri-operative care of transgender and gender-diverse individuals: new guidance for clinicians and departments published

2024-07-24
New guidance on peri-operative care of transgender and gender-diverse individuals is today published in Anaesthesia (the journal of the Association of Anaesthetists) to guide best practice to ensure the safety and dignity of transgender and gender-diverse people in the peri-operative period. The guidance has been produced by a working group of experts including Dr Stuart Edwardson, Royal Infirmary of Edinburgh, Edinburgh, UK, and Dr Luke Flower, Victor Philip Dahdaleh Heart and Lung Research Institute, Cambridge, UK, and colleagues. The number of people openly identifying ...

Clinical psychologist’s book addresses largely ignored problem: social anxiety

Clinical psychologist’s book addresses largely ignored problem: social anxiety
2024-07-23
RIVERISDE, Calif. -- We all have some social anxiety. The nervousness we might feel before giving a speech is one example. Some people, however, have more social anxiety than others, and limit their social engagement due to excessive chronic fears of being embarrassed or humiliated. Although such social anxiety is common in both adolescents and adults, it is rarely diagnosed and treated. In a new book titled “Social Anxiety: Hidden Fears and Shame in Teens and Adults,” Thomas E. Brown, a clinical professor of psychiatry and neuroscience in the University of California, Riverside's School of Medicine , explains ...

LAST 30 PRESS RELEASES:

ASH 2025: Study suggests that a virtual program focusing on diet and exercise can help reduce side effects of lymphoma treatment

A sound defense: Noisy pupae puff away potential predators

Azacitidine–venetoclax combination outperforms standard care in acute myeloid leukemia patients eligible for intensive chemotherapy

Adding epcoritamab to standard second-line therapy improves follicular lymphoma outcomes

New findings support a chemo-free approach for treating Ph+ ALL

Non-covalent btki pirtobrutinib shows promise as frontline therapy for CLL/SLL

University of Cincinnati experts present research at annual hematology event

ASH 2025: Antibody therapy eradicates traces of multiple myeloma in preliminary trial

ASH 2025: AI uncovers how DNA architecture failures trigger blood cancer

ASH 2025: New study shows that patients can safely receive stem cell transplants from mismatched, unrelated donors

Protective regimen allows successful stem cell transplant even without close genetic match between donor and recipient

Continuous and fixed-duration treatments result in similar outcomes for CLL

Measurable residual disease shows strong potential as an early indicator of survival in patients with acute myeloid leukemia

Chemotherapy and radiation are comparable as pre-transplant conditioning for patients with b-acute lymphoblastic leukemia who have no measurable residual disease

Roughly one-third of families with children being treated for leukemia struggle to pay living expenses

Quality improvement project results in increased screening and treatment for iron deficiency in pregnancy

IV iron improves survival, increases hemoglobin in hospitalized patients with iron-deficiency anemia and an acute infection

Black patients with acute myeloid leukemia are younger at diagnosis and experience poorer survival outcomes than White patients

Emergency departments fall short on delivering timely treatment for sickle cell pain

Study shows no clear evidence of harm from hydroxyurea use during pregnancy

Long-term outlook is positive for most after hematopoietic cell transplant for sickle cell disease

Study offers real-world data on commercial implementation of gene therapies for sickle cell disease and beta thalassemia

Early results suggest exa-cel gene therapy works well in children

NTIDE: Disability employment holds steady after data hiatus

Social lives of viruses affect antiviral resistance

Dose of psilocybin, dash of rabies point to treatment for depression

Helping health care providers navigate social, political, and legal barriers to patient care

Barrow Neurological Institute, University of Calgary study urges “major change” to migraine treatment in Emergency Departments

Using smartphones to improve disaster search and rescue

Robust new photocatalyst paves the way for cleaner hydrogen peroxide production and greener chemical manufacturing

[Press-News.org] Expanding APAC presence, Insilico Medicine seals strategic collaboration on AI-driven mash therapy development with Korean Biotech Therasid Bioscience